Article 145: The Speed Demons of Drug Development

• Based on CenterWatch analysis of more than 725 NCEs approved since 1981, AstraZeneca, GlaxoWellcome and Merck are among the five fastest companies at clinical development.
• Fastest companies cite several key factors driving development speed, including more globally-oriented development planning, more substantive communications with regulatory authorities and the use of data management technologies.

Article 146: Alternative Medicine's Move into Clinical Trials

• Consumer sales of alternative medicines have dramatically increased in the past 10 years
• Despite several hurdles, pharmaceutical companies are expected to increase clinical trials of botanicals to gain competitive advantages.

Article 147: Centre Stage Europe: Profiad Secures Investment for Global Expansion

Article 148: Eye On Migraine: 18 Drugs in Research for Migraine

• CenterWatch editorial has identified approximately 18 drugs in clinical testing for migraines and at least eight others are close to entering early phases of clinical testing.